nach oben

memo - Magazine of European Medical Oncology

Inhalt (1 Artikel)

Supplement 1/18

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

Aktuelle Ausgaben

memo - Magazine of European Medical Oncology 1/2024
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology
memo - Magazine of European Medical Oncology 1/2024
memo - Magazine of European Medical Oncology 4/2023
memo - Magazine of European Medical Oncology 8/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress
memo - Magazine of European Medical Oncology 9/2023
A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna
memo - Magazine of European Medical Oncology 10/2023
A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA
memo - Magazine of European Medical Oncology 11/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain
memo - Magazine of European Medical Oncology 12/2023
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023
memo - Magazine of European Medical Oncology 3/2023
memo - Magazine of European Medical Oncology 6/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ASCO Hybrid Congress , 2nd – 6th June 2023

Scrollen für mehr

Benutzen Sie die Pfeiltasten für mehr

Scrollen oder Pfeiltasten für mehr

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

24.04.2024 | DGIM 2024 | Nachrichten

Bei Senioren mit Prostatakarzinom auf Anämie achten!

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

ICI-Therapie in der Schwangerschaft wird gut toleriert

weitere anzeigen

Springer Medizin

memo - Magazine of European Medical Oncology

Ausgabe Sonderheft 1/2018

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

Inhalt (1 Artikel)

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

Aktuelle Ausgaben

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

memo - Magazine of European Medical Oncology 1/2024

memo - Magazine of European Medical Oncology 4/2023

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress

A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna

A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023

memo - Magazine of European Medical Oncology 3/2023

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ASCO Hybrid Congress , 2nd – 6th June 2023

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie